746P EV-201: Long-term results of enfortumab vedotin monotherapy for locally advanced or metastatic urothelial cancer previously treated with platinum and PD-1/PD-L1 inhibitors.

Authors :: O'Donnell, P.
Galsky, M.D.
Rosenberg, J.E.
Petrylak, D.P.
Balar, A.V.
McGregor, B.A.
Heath, E.
Yu, E.Y.
Quinn, D.I.
Hahn, N.M.
Campbell, M.
Liang, S-Y.
Steinberg, J.
Loriot, Y.
Source :: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS579-S580. 2p.
Publication Year :: 2020

Subjects :: *TRANSITIONAL cell carcinoma
*PROGRAMMED cell death 1 receptors
*PROGRAMMED death-ligand 1
*METASTASIS
*PLATINUM

Full Text Access

Tools